Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Doxorubicin hydrochloride (in heat-sensitive liposomes)

EU orphan designation number: EU/3/10/833   
Active ingredient: Doxorubicin hydrochloride (in heat-sensitive liposomes)
Indication: Treatment of hepatocellular carcinoma
Sponsor: Biological Consulting Europe Ltd
Wallace Building, Roslin BioCentre, Roslin, Midlothian, EH25 9PP, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/096/10 (2011)1299 of 23/02/2011
29/08/2014 Centralised Orphan - Change of address